# Therapeutic targeting of circ-ZNF609 attenuates cardiac remodeling by modulating the expression of ZEB1

Source: [cell.com](https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00589-6?rss=yes) · 2026-11-19 · Medicine
Page: https://themorning.science/story/therapeutic-targeting-of-circ-znf609-attenuates-cardiac-remodeling-by-modulating-070d9f2eb65b7c21
Kind: research · Impact: low

## In brief

- The study identifies circ-ZNF609 as a regulator of pressure overload-induced cardiac remodeling in mice.
- Both shRNA and CRISPR-hfCas13x strategies targeting circ-ZNF609 attenuated this remodeling.
- circ-ZNF609 interacts with YTHDF3, and the work links its effect to modulation of ZEB1 expression.

## Why it matters

It offers a preclinical RNA-targeting approach to pressure overload-induced cardiac remodeling, a process relevant to heart failure research. The results are from mice, so their relevance to human disease is not yet established.

## Coverage

- [Therapeutic targeting of circ-ZNF609 attenuates cardiac remodeling by modulating the expression of ZEB1](https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00589-6?rss=yes) — cell.com, 2026-11-19

Tags: circular rna, cardiac remodeling, heart failure, mouse model, rna therapeutics

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
